Literature DB >> 12142260

Use of oral contraceptive pills and vulvar vestibulitis: a case-control study.

Céline Bouchard1, Jacques Brisson, Michel Fortier, Carol Morin, Caty Blanchette.   

Abstract

Vulvar vestibulitis is characterized by superficial pain during intercourse. Exploratory studies have suggested that oral contraceptives (OCs) could be associated with occurrence of vulvar vestibulitis. This 1995-1998 case-control study in Québec, Canada, sought to reassess this association. Included were 138 women with vulvar vestibulitis whose symptoms had appeared in the previous 2 years and 309 age-matched controls who were consulting their physicians for reasons other than gynecologic problems or contraception. Cases and controls were interviewed to obtain a detailed history of OC use and information on potential confounding factors. Relative risks were estimated by using logistic regression. The authors found that 4 percent of cases had never used OCs compared with 17 percent of controls. The relative risk of vulvar vestibulitis was 6.6 (95 percent confidence interval: 2.5, 17.4) for ever users compared with never users. When OCs were first used before age 16 years, the relative risk of vulvar vestibulitis reached 9.3 (95 percent confidence interval: 3.2, 27.2) and increased with duration of OC use up to 2-4 years. The relative risk was higher when the pill used was of high progestogenic, high androgenic, and low estrogenic potency. The possibility that OC use may contribute to the occurrence of vulvar vestibulitis needs to be evaluated carefully.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142260     DOI: 10.1093/aje/kwf037

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  17 in total

Review 1.  Hormonal contraception and pelvic floor function: a systematic review.

Authors:  Rita Champaneria; Ruben Mamprin D'Andrea; Pallavi M Latthe
Journal:  Int Urogynecol J       Date:  2015-09-25       Impact factor: 2.894

Review 2.  [Review of the literature on the psychoemotional reality of women with vulvodynia: difficulties met and strategies developed].

Authors:  M Cantin-Drouin; D Damant; D Turcotte
Journal:  Pain Res Manag       Date:  2008 May-Jun       Impact factor: 3.037

3.  Differences in primary compared with secondary vestibulodynia by immunohistochemistry.

Authors:  Catherine M Leclair; Martha F Goetsch; Veselina B Korcheva; Ross Anderson; Dawn Peters; Terry K Morgan
Journal:  Obstet Gynecol       Date:  2011-06       Impact factor: 7.661

4.  Persistent genital hyperinnervation following progesterone administration to adolescent female rats.

Authors:  Zhaohui Liao; Peter G Smith
Journal:  Biol Reprod       Date:  2014-10-30       Impact factor: 4.285

5.  Female sexual dysfunction with combined oral contraceptive use.

Authors:  Jean Jasmin M L Lee; Thiam Chye Tan; Seng Bin Ang
Journal:  Singapore Med J       Date:  2017-06       Impact factor: 1.858

6.  Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey.

Authors:  Gloria A Bachmann; Raymond Rosen; Lauren Denise Arnold; Irina Burd; George G Rhoads; Sandra R Leiblum; Nancy Avis
Journal:  J Reprod Med       Date:  2006-01       Impact factor: 0.142

7.  Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse.

Authors:  E Rylander; A-L Berglund; C Krassny; B Petrini
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

8.  Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.

Authors:  Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2004-01-15       Impact factor: 4.897

9.  Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response.

Authors:  Candace S Brown; David C Foster; Jim Y Wan; Leslie A Rawlinson; Gloria A Bachmann
Journal:  Contemp Clin Trials       Date:  2013-06-29       Impact factor: 2.226

10.  Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study.

Authors:  B D Reed; S D Harlow; L J Legocki; M E Helmuth; H K Haefner; B W Gillespie; A Sen
Journal:  BJOG       Date:  2013-08-13       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.